Table 3.

Follow-Up Investigation of Six Eyes

		Mean ± SD (ps)
Area	Channel	Baseline	Follow-Up	P
Fovea	SSC	171 ± 25	180 ± 23	0.275
	LSC	252 ± 17	259 ± 14	0.058
Hyperfluorescent	SSC	295 ± 28	301 ± 32	0.310
	LSC	358 ± 18	362 ± 18	0.325
Periphery	SSC	295 ± 28	301 ± 32	<0.05
	LSC	491 ± 35	536 ± 46	<0.05

Baseline and follow-up FLIO lifetimes in three patients with CHM (patients 5, 8, and 11). P < 0.05 indicates significance.